Resultaterne af de fremlagte undersøgelser viste, at de thiomersalfrie vacciner ved afslutningen af vaccinationsforløbet gav det samme niveau af antistoffer, der beskytter imod hepatitis B- virus, som de vacciner, der indeholdt thiomersal.
The results of the studies presented showed that the thiomersal-free vaccines produced protective levels of antibodies against hepatitis B virus to a similar extent to the vaccines that contained thiomersal at the end of the vaccination course.